Skip to content

Efficacy of a Tea Catechin Sports Drink for Enhancing Exercise-Induced Fat Loss

A Randomized, Double-Blind, Controlled Study to Assess the Efficacy of a Tea Catechin Sports Drink for Enhancing Exercise-Induced Fat Loss

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00692731
Enrollment
132
Registered
2008-06-06
Start date
2006-06-30
Completion date
2007-08-31
Last updated
2008-06-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Overweight

Keywords

green tea,, polyphenols,, weight loss,, body fat

Brief summary

The primary objective of this trial is to evaluate the influence of consuming a tea catechin containing sports beverage on body fat mass during exercise-induced weight loss among overweight and obese men and women.

Detailed description

The study will include two screening/baseline visits and six treatment visits over 12 weeks. During the treatment phase of the study, subjects will be instructed to consume one bottle of sports drink (500 ml) daily (total consumption of tea catechins in the active group = 540 mg/d). Subjects will be asked to maintain a constant energy intake throughout the study period. Three-day diet records will be collected and analyzed at weeks 0, 6, and 12 to evaluate consistency of energy intake. All subjects will engage in an exercise program with a goal of maintaining 180 min/week of low- to moderate-intensity exercise (e.g., walking and other aerobic activities, 4-6 days per week). Three of the weekly exercise sessions will be supervised and 1-3 will be unsupervised. Subjects will be asked to wear a pedometer and record their daily physical activity (steps) each night in a physical activity diary. Diaries will be collected at each visit and used to evaluate exercise compliance. Dual energy X-ray absorptiometry (DEXA) and computed tomography (CT) scans will be performed at baseline (week 0) and at the end of the treatment (week 12). Additionally, body weight and abdominal circumference will be assessed at every clinic visit during the study. It is anticipated that subjects will expend 1000-1800 kcal per week above their baseline level in deliberate physical activity. Accordingly, the control group is expected to lose 1.5 to 2.8 kg of body fat during the 12-week treatment period

Interventions

DIETARY_SUPPLEMENT500 mL/day of a beverage providing approximately 625 mg catechins

Subjects were asked to consume 500 mL/day of a beverage providing approximately 625 mg catechins

OTHERControl beverage matched for energy and caffeine content

500 mL/day of a control beverage

Sponsors

Kao (Taiwan) Corporation
CollaboratorINDUSTRY
Provident Clinical Research
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
21 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Men and women 21 to 65 years of age, inclusive * Waist circumference ≥ 87 cm for women and ≥ 90 cm for men at screening * Total cholesterol ≥ 200 mg/dL * Provide written informed consent and authorization for protected health information

Exclusion criteria

* Volunteers with Body mass index ≥ 40.0 kg/m2 or \< 25.0 kg/m2; * Recent weight loss of more than 4.5 kg; * Recent use of any weight loss medications, supplements, or programs; * History of weight-reducing surgery or an eating disorder * Pregnancy

Design outcomes

Primary

MeasureTime frame
Changes in body fat mass.Baseline to end-of-treatment

Secondary

MeasureTime frame
Changes in body weightBaseline to end-of-treatment

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026